Imaging News and Research

RSS

New study raises doubts about benefits of ezetimibe in patients suffering from high LDL cholesterol

More than 42 million Americans suffer from high cholesterol, and 63 million more have borderline high cholesterol. Over time, high levels of LDL cholesterol, often called "bad cholesterol," build up along the walls of arteries and blood vessels, a process called atherosclerosis, which can lead to a high risk of heart disease, stroke and heart attack.

21 May 2011

Healthy breakfast containing protein-rich foods can help people stay satisfied longer

A University of Missouri researcher has found that eating a healthy breakfast, especially one high in protein, increases satiety and reduces hunger throughout the day. In addition, using functional magnetic resonance imaging (fMRI) the researchers found that eating a protein-rich breakfast reduces the brain signals controlling food motivation and reward-driven eating behavior.

20 May 2011

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Six-month results from the BIOSOLVE-I first-in-man (FIM) trial, studying the DRug-Eluting Absorbable Metal Scaffold (DREAMS), demonstrate a high safety profile of the novel device.

19 May 2011

Treadmill test helps predict lifetime risk of cardiovascular disease in middle-age people

In two separate studies, UT Southwestern Medical Center researchers have found that how fast a middle-age person can run a mile can help predict the risk of dying of heart attack or stroke decades later for men and could be an early indicator of cardiovascular disease for women.

19 May 2011

Berkeley Lab scientists contribute to remarkable advance in nuclear magnetic resonance

Nuclear magnetic resonance, a scientific technique associated with outsized, very low temperature, superconducting magnets, is one of the principal tools in the chemist's arsenal, used to study everything from alcohols to proteins to such frontiers as quantum computing.

19 May 2011

New image-processing software allows significant radiation dose reduction

A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.

18 May 2011

Schryver Medical adopts Zmanda's backup and disaster recovery solutions to backup critical enterprise data

Zmanda™, the industry's leading provider of open source backup and disaster recovery solutions, today announced that Schryver Medical, Inc. has adopted Amanda Enterprise to backup the company's mission critical enterprise data. The company is also in the process of deploying Zmanda's Disaster Recovery module to ensure they meet all regulatory compliance and uptime requirements.

18 May 2011

U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound system

U-Systems, the leader in automated breast ultrasound, launched a revolutionary new transducer technology designed to deliver unparalleled imaging performance and patient comfort. Reverse-Curve Crystal™ (RCC) Transducer Technology was designed and optimized for use with the U-Systems' somo•v® Automated Breast Ultrasound (ABUS) system.

18 May 2011

Clinical PET system for early stage breast cancer diagnosis

European researchers have developed a clinical PET system with the highest resolution and sensitivity in the market, specifically dedicated to breast cancer detection in early stages.

18 May 2011

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the first quarter ended March 31, 2011.

18 May 2011

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer’s disease published recently by the National Institute on Aging (NIA) and the Alzheimer’s Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer’s disease at a preclinical stage, Mild Cognitive Impairment (MCI) due to Alzheimer’s disease, and dementia due to Alzheimer’s pathology.

18 May 2011

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon technology.

From Medtronic 17 May 2011

Study achieves 5-fold reduction in Tc-99m sestamibi dosage for molecular breast imaging

Published in the April issue of Journal of Nuclear Medicine, Gamma Medica, Inc. and Mayo Clinic of Rochester, MN document the achievement of a 5-fold reduction in the necessary dose of Tc-99m sestamibi to perform Molecular Breast Imaging (MBI). This achievement enables the new LumaGEM™ MBI System by Gamma Medica to deliver the same low radiation dose as digital screening mammography.

17 May 2011

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.

17 May 2011

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S. indicates the agents do not appear to be any more effective than traditional blood thinners for the majority of these patients.

17 May 2011

'Mu opioid' receptors in the brain linked to smoking relapse

Nearly everyone who has tried to quit smoking says it's incredibly difficult, and the struggle is due in part to genetic factors. Now, a new study from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania sheds light on how one specific genetic risk for smoking relapse may work: Some of the difficulties may be due to how many receptors, called "mu opioid" receptors, a smoker has in his or her brain.

17 May 2011

Super-resolution microscopy technique reveals how and why cell's defenses fail against plague

Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli.

17 May 2011

City of Philadelphia chooses eClinicalWorks' EHR suite to help improve patient care

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that the City of Philadelphia has selected the company to help improve the continuity of care for the City's Department of Public Health.

16 May 2011

IOD completes acquisition of Confidential Copiers

IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced the completion of a strategic acquisition of Confidential Copiers Inc.

16 May 2011

Volcano to share intravascular therapy guidance and optimization solutions at EuroPCR

Volcano Corporation today announced its participation in the Paris course for Revascularization from May 17 – 20. Volcano's focus will be on highlighting the strength of its product portfolio, which includes innovative devices like the Vascular Imaging Balloon Catheter, and its sponsorship of a symposium that highlights the use and value of Precision Guided Therapy in clinical practice today.

16 May 2011

Imaging News and Research

New study raises doubts about benefits of ezetimibe in patients suffering from high LDL cholesterol

Healthy breakfast containing protein-rich foods can help people stay satisfied longer

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Treadmill test helps predict lifetime risk of cardiovascular disease in middle-age people

Berkeley Lab scientists contribute to remarkable advance in nuclear magnetic resonance

New image-processing software allows significant radiation dose reduction

Schryver Medical adopts Zmanda's backup and disaster recovery solutions to backup critical enterprise data

U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound system

Clinical PET system for early stage breast cancer diagnosis

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

Study achieves 5-fold reduction in Tc-99m sestamibi dosage for molecular breast imaging

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

'Mu opioid' receptors in the brain linked to smoking relapse

Super-resolution microscopy technique reveals how and why cell's defenses fail against plague

City of Philadelphia chooses eClinicalWorks' EHR suite to help improve patient care

IOD completes acquisition of Confidential Copiers

Volcano to share intravascular therapy guidance and optimization solutions at EuroPCR

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News